Bulletin
Investor Alert

London Markets Close in:

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 19, 2021, 10:53 a.m.

/zigman2/quotes/210293917/composite

$

66.53

Change

+0.63 +0.96%

Volume

Volume 1.75m

Real time quotes

/zigman2/quotes/210293917/composite

Previous close

$ 65.90

$ 66.53

Change

+0.63 +0.96%

Day low

Day high

$65.86

$66.59

Open

52 week low

52 week high

$56.56

$73.34

Open

Insider Actions for Gilead Sciences Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/17/2021 Diane E. Wilfong
SVP, Controller & CAO
13,610   Disposition at $72.5 per share. 986,725
08/17/2021 Diane E. Wilfong
SVP, Controller & CAO
3,829   Derivative/Non-derivative trans. at $66.36 per share. 254,092
08/17/2021 Diane E. Wilfong
SVP, Controller & CAO
9,781   Derivative/Non-derivative trans. at $68.75 per share. 672,443
08/15/2021 Andrew D. Dickinson
Chief Financial Officer
1   Award at $55.08 per share. 55
08/15/2021 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
32   Award at $55.08 per share. 1,762
08/15/2021 Merdad V. Parsey
Chief Medical Officer
1   Award at $55.08 per share. 55
08/10/2021 Diane E. Wilfong
SVP, Controller & CAO
907   Derivative/Non-derivative trans. at $69.24 per share. 62,800
08/10/2021 Diane E. Wilfong
SVP, Controller & CAO
2,480   Derivative/Non-derivative trans. at $0 per share. 0
07/24/2021 Johanna Mercier
Chief Commercial Officer
3,425   Derivative/Non-derivative trans. at $69.02 per share. 236,393
07/24/2021 Johanna Mercier
Chief Commercial Officer
7,505   Derivative/Non-derivative trans. at $0 per share. 0
06/15/2021 Javier J. Rodriguez
Director
1,838   Derivative/Non-derivative trans. at $0 per share. 0
06/10/2021 Andrew D. Dickinson
Chief Financial Officer
1,605   Derivative/Non-derivative trans. at $69.29 per share. 111,210
06/10/2021 Andrew D. Dickinson
Chief Financial Officer
3,646   Derivative/Non-derivative trans. at $0 per share. 0
05/06/2021 Per Wold-Olsen
Director
1,936   Derivative/Non-derivative trans. at $0 per share. 0
05/06/2021 Richard J. Whitley
Director
1,936   Derivative/Non-derivative trans. at $0 per share. 0
05/06/2021 Jacqueline K. Barton
Director
1,936   Derivative/Non-derivative trans. at $0 per share. 0
05/06/2021 Harish M. Manwani
Director
1,936   Derivative/Non-derivative trans. at $0 per share. 0
05/04/2021 Johanna Mercier
Chief Commercial Officer
19,496   Disposition at $66.09 per share. 1,288,490
05/03/2021 Richard J. Whitley
Director
20,282   Disposition at $64.57 per share. 1,309,608
05/03/2021 Richard J. Whitley
Director
20,282   Derivative/Non-derivative trans. at $20.64 per share. 418,620
03/11/2021 Brett A. Pletcher
EVP,Corp Affairs & Gen Counsel
1,486   Disposition at $63.36 per share. 94,152

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
7 Purchases
3 Sales
23,629
17,942
Last 6 months
14 Purchases
6 Sales
57,139
59,325
Last 12 months
46 Purchases
28 Sales
334,096
158,987

Officers and Executives

Mr. Daniel P. O'Day
Chairman & Chief Executive Officer
Mr. Andrew D. Dickinson
Chief Financial Officer
Dr. Merdad V. Parsey
Chief Medical Officer
Dr. Flavius Martin
Executive Vice President-Research
Ms. Johanna Mercier
Chief Commercial Officer
Dr. Tomas Cihlar
Vice President-Virology
Dr. Linda Slanec Higgins
Senior VP-Research & External Innovation
Dr. Mark Genovese
Senior Vice President-Inflammation
Dr. Michael Quigley
Senior Vice President-Research Biology
Ms. Janet Dorling
SVP-Global Commercial Product Strategy
Ms. Monica Tellado
Senior Vice President-Finance
Dr. William Grossman
Senior Vice President-Oncology Clinical Research
Mr. Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Dr. Taiyin Yang
EVP-Pharmaceutical Development & Manufacturing
Mr. Michael Louie
Vice President-Information Systems
Ms. Diane E. Wilfong
Chief Accounting Officer & Senior Vice President
Ms. Jacquie Ross
Investor Relations Contact
Ms. Jyoti Mehra
Executive Vice President-Human Resources
Dr. Sandra J. Horning
Independent Director
Mr. Javier J. Rodriguez
Independent Director
Mr. Anthony Welters
Independent Director
Dr. Jeffrey A. Bluestone
Independent Director
Mr. Kevin E. Lofton
Lead Independent Director
Ms. Kelly A. Kramer
Independent Director
Dr. Jacqueline K. Barton
Independent Director
Mr. Harish M. Manwani
Independent Director
Link to MarketWatch's Slice.